Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,102	$ 1,451
Accounts and notes receivable, net	626	720
Inventories	1,404	1,099
Prepaid expenses and other	82	75
Total current assets	3,214	3,345
Property, plant, and equipment	9,387	9,232
Less: Accumulated depreciation	(6,216)	(6,078)
Property, plant, and equipment, net	3,171	3,154
Operating lease right-of-use assets	240	227
Goodwill	102	102
Other intangible assets, net	13	6
Investments in affiliates	175	169
Restricted cash and restricted cash equivalents	202	100
Other assets	523	447
Total assets	7,640	7,550
Current liabilities:
Accounts payable	1,251	1,162
Compensation and other employee-related cost	121	173
Short-term and current maturities of long-term debt	25	25
Current environmental remediation	194	173
Other accrued liabilities	300	325
Total current liabilities	1,891	1,858
Long-term debt, net	3,590	3,724
Operating lease liabilities	198	179
Long-term environmental remediation	474	389
Deferred income taxes	61	49
Other liabilities	319	269
Total liabilities	6,533	6,468
Commitments and contingent liabilities
Equity
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 195,375,810 shares issued and 148,504,030 shares outstanding at December 31, 2022; 191,860,159 shares issued and 161,046,732 shares outstanding at December 31, 2021)	2	2
Treasury stock, at cost (46,871,780 shares at December 31, 2022; 30,813,427 shares at December 31, 2021)	(1,738)	(1,247)
Additional paid-in capital	1,016	944
Retained earnings	2,170	1,746
Accumulated other comprehensive loss	(343)	(364)
Total Chemours stockholders’ equity	1,107	1,081
Non-controlling interests		1
Total equity	1,107	1,082
Total liabilities and equity	$ 7,640	$ 7,550